The enterprise digital pathology platform, powered by Tribun Health, integrates pathology, radiology, and cardiology imaging ...

Watchmaker Genomics launched a PCR-free whole genome sequencing workflow integrating library prep and normalization.

Ozelle will present its AI-assisted hematology analyzer at MEDICA 2026, offering CBC, 7-part WBC differentials, and digital ...

FDA clears Sekisui Diagnostics’ rapid combo test for COVID-19 and flu A&B, offering CLIA-waived, 510(k)-cleared pathogen ...

Path Fertility secures $2 million NIH grant to develop and validate a semen-based epigenetic assay for NOA and cancer risk.

Agendia presented data on an AI pathology model that predicts breast cancer recurrence risk from routine biopsy slides.

Abbott launches its Oncodetect MRD test, using WGS to track up to 5,000 variants and improve cancer recurrence detection sensitivity.

Tempus xR RNA sequencing assay receives EU IVDR Class C certification, supporting continued clinical and biopharma access in ...

Medicare now reimburses Lucid Diagnostics’ EsoGuard esophageal DNA test at $1,938 per test, following its $15 million private placement.

Hologic has agreed to acquire Reveal Genomics, adding the HER2DX assay to its breast cancer genomic testing portfolio, the ...